NCT05556928
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +19 more
- Locations
-
- Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,963 public trials
2,020 recruiting studies
Immunoproliferative Disorders trial results
Recruiting
Registry of the German CLL Study Group
NCT02863692
- Conditions
- CLL, HCL, Hematologic Diseases, +19 more
- Locations
-
- BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Dresden, Saxony, Germany
NCT07270679
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
NCT06421948
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
- Liling Zhang Wuhan, Hubei, China
- Yajun Li Changsha, Hunan, China
- Ming Jiang Chengdu, Sichuan, China
Recruiting
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
NCT04925609
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Granuloma, Granuloma, Plasma Cell, +15 more
- Locations
-
- Institut Gustave Roussy Paris, France
- Princess Máxima Center for Pediatric Oncology Utrecht, Netherlands
NCT05168930
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
- Locations
-
- New England Cancer Specialists Scarborough, Maine, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- South Shore Hospital South Weymouth, Massachusetts, United States
NCT06986174
- Conditions
- B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
NCT07014319
- Conditions
- Cytomegalovirus (CMV), Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT06520163
- Conditions
- Hematopoietic Stem Cell Mobilization, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Dongyang People's Hospital Dongyang, Zhejiang, China
- The Affiliated Hangzhou First People's Hospital Hangzhou, Zhejiang, China
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Tongde Hospital of Zhejiang Province Hangzhou, Zhejiang, China
NCT04871607
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States